During pregnancy, the immune system also changes.
These adaptations are necessary for a successful pregnancy.
The mother's immune system cannot simply switch off.
It must continue protecting her from infection while supporting the development of the fetus.
This requires a carefully regulated balance.
In some circumstances, however, an infection or another immune stimulus may produce a stronger or more prolonged inflammatory response.
Scientists refer to the experimental activation of this process during pregnancy as maternal immune activation.
The September 2026 study investigated how such activation could influence the placenta and developing embryos.
What Is Maternal Immune Activation?
Maternal immune activation does not necessarily mean that a pregnant woman has a severe infection.
It describes a biological process in which the maternal immune system becomes activated.
The activation may occur in response to infection or, in experimental studies, through substances that stimulate immune pathways.
In the Cold Spring Harbor Laboratory experiments, the researchers used poly(I:C).
Poly(I:C) is a synthetic molecule that mimics certain features of viral genetic material.
The immune system recognizes it through pathways associated with antiviral defense.
This makes it useful for studying how an immune response might influence pregnancy without introducing an actual infectious virus into the experimental animals.
The researchers could therefore examine the consequences of immune activation under controlled laboratory conditions.
This distinction is important.
The experiment was not designed to show that a particular virus causes autism.
It was designed to investigate how an activated immune system might influence early fetal and placental development.
Why the Timing of Inflammation Matters
One of the most interesting aspects of the research was the apparent importance of timing.
Pregnancy is not a single, uniform developmental stage.
The fetus changes rapidly as organs, tissues, and biological systems develop.
A biological signal that has little effect at one stage may have a different effect at another.
The researchers tested immune activation at different stages of mouse pregnancy.
They found that approximately 12.5 days into pregnancy represented a particularly sensitive period in their experimental model.
At this stage, approximately 30 percent of embryos showed significant developmental abnormalities within 24 hours of immune activation.
The abnormalities included changes in fetal growth and sensory-organ development.
This rapid response attracted attention because it suggested that some developmental disruptions could begin much earlier than the researchers had previously been able to observe.
However, the 12.5-day mouse pregnancy finding must not be translated directly into a particular week of human pregnancy.
Mouse gestation is much shorter than human gestation, and developmental processes do not align perfectly day by day.
The result identifies a sensitive window in the experimental mouse model.
It does not establish a specific dangerous period for human pregnancies.
The Surprising Difference Between Male and Female Embryos
Perhaps the most striking observation in the research was the difference between male and female embryos.
According to the published findings, the developmental abnormalities appeared in a subset of male embryos.
Female embryos did not show the same abnormalities in the experiments described.
This raised an important question: could biological sex influence how embryos respond to inflammation during pregnancy?
Researchers have long investigated why autism is diagnosed more frequently in boys than girls.
The reasons are complex.
Genetic factors, biological development, diagnostic practices, and differences in how autism presents across individuals may all contribute to the observed differences.
The Cold Spring Harbor Laboratory study offers another possible area for investigation.
The researchers suggested that male embryos may have particular biological characteristics that make them more vulnerable to certain inflammatory signals.
They also considered whether female embryos might possess protective mechanisms that help them withstand the same immune challenge.
These are research questions, not established explanations for the difference in autism diagnosis rates between boys and girls.
Why the Sex Difference Was Unexpected
One reason the observation attracted attention was the developmental stage at which it occurred.
The researchers noted that the difference appeared before several later processes associated with sexual differentiation in the brain.
This suggested that the observed vulnerability might involve mechanisms operating very early in development.
It also raised the possibility that the placenta itself could contribute to sex-related differences.
The researchers were interested in understanding why embryos exposed to the same maternal immune activation did not respond identically.
Some male embryos developed normally.
Others showed substantial abnormalities.
Female embryos did not show the same pattern in the reported experiments.
This means that biological sex alone did not determine the outcome.
The findings pointed toward a combination of factors involving placental function, immune signaling, and the characteristics of individual embryos.
Could Female Embryos Have a Protective Mechanism?
The research team proposed that female embryos might possess biological protection that helps prevent certain inflammatory effects.
This is an intriguing possibility.
If scientists can identify the mechanisms involved, they may eventually gain a better understanding of why some embryos are more resilient than others.
However, the idea remains a hypothesis requiring additional experiments.
It would be incorrect to conclude that female fetuses are protected from autism or that male fetuses are destined to develop autism after maternal inflammation.
Neither statement is supported by the research.
Autism occurs in people of all sexes.
Its development involves many interacting biological and environmental factors.
The mouse findings may help researchers explore one particular mechanism, but they cannot be used to predict an individual child's future.
The Role of Spongiotrophoblasts in the Study
The focus on spongiotrophoblasts is particularly important because it connects the research findings to the structure of the placenta.
These specialized cells are part of the junctional zone in the mouse placenta.
They help support placental function and contribute to the biological environment at the maternal-fetal interface.
In the research, the scientists examined these cells to understand why certain embryos developed abnormalities after maternal immune activation.
They observed that the spongiotrophoblasts in affected male embryos showed signs of damage.
The cells also displayed changes in the activity of genes associated with inflammation, extracellular matrix organization, and hormone production.
The extracellular matrix is the network of proteins and other substances that helps provide structural support to tissues.
When its organization changes, the physical structure of a tissue can also be affected.
The researchers found evidence of a breakdown in placental structural integrity in affected embryos.
They also observed changes in immune cells and inflammatory signaling within the amniotic environment.
These findings suggested that the problem was not limited to one isolated cell type.
Instead, maternal immune activation appeared to influence a broader biological network involving the placenta and the developing embryo.
Why Placental Structure Matters
The placenta must maintain its structure to perform its functions.
Its cells and tissues work together to support nutrient exchange, hormone production, and communication between maternal and fetal systems.
If the structure of an important placental region becomes disrupted, its ability to regulate the environment may also change.
The researchers proposed that damage to the junctional zone could interfere with the normal protective balance between maternal and fetal immune activity.
In their model, this change was associated with the appearance of developmental abnormalities in vulnerable male embryos.
This is important because it suggests that the placenta may be more than a passive structure affected by inflammation.
It may actively participate in determining how inflammatory signals influence fetal development.
However, more research is necessary to determine whether comparable cell populations and pathways have the same roles in human pregnancy.
Interleukin-6: An Important Inflammatory Signal
Another important finding involved a signaling molecule called interleukin-6, commonly abbreviated as IL-6.
Interleukin-6 is a cytokine.
Cytokines are proteins used by cells to communicate during immune responses and other biological processes.
They help coordinate inflammation, immune-cell activity, tissue repair, and several aspects of normal physiology.
IL-6 can be beneficial in appropriate circumstances.
For example, it participates in the body's response to infection and helps coordinate immune defenses.
However, excessive or poorly regulated inflammatory signaling can have harmful effects depending on the circumstances.
In the September 2026 mouse study, IL-6 was identified as necessary for the maternal immune activation-associated developmental abnormalities observed in the experimental model.
This finding provided another piece of evidence linking inflammatory signaling to the placental changes and developmental outcomes.
It also suggested that researchers should investigate specific cytokines rather than treating inflammation as one general process.
Why IL-6 Attracted Scientific Attention
IL-6 is involved in several biological pathways.
It can influence immune-cell behavior and affect how tissues respond to inflammatory conditions.
Researchers have investigated IL-6 in many areas of medicine, including infectious diseases, autoimmune conditions, and neurodevelopmental research.
In studies of maternal immune activation, cytokines have attracted attention because they provide a possible communication route between the maternal immune system and the developing fetus.